Log In
Print
BCIQ
Print
Print this Print this
 

palbociclib (PD-0332991)

  Manage Alerts
Collapse Summary General Information
Company Onyx Pharmaceuticals Inc.
DescriptionOral small molecule cyclin dependent kinase 4 (CDK4) and CDK6 inhibitor
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today